Sign In | Join Free | My himfr.com
himfr.com

Chongqing Newsin Technology Co., Ltd

engaged in the Manufacturing, Sales, Research of chemicals and special materials.

Active Member

10 Years

Home > APIs >

Omarigliptin (MK-3102) [1226781-44-7]

Chongqing Newsin Technology Co., Ltd
Contact Now
  • Product Details
  • Company Profile

Omarigliptin (MK-3102) [1226781-44-7]

Name(2R,3S,5R)-2-(2,5-Difluorophenyl)-5-[2-(methylsulfonyl)-2,6-dihydropyrrolo[3,4-c]pyrazol-5(4H)-yl]tetrahydro-2H-pyran-3-amine
Molecular FormulaC17H20F2N4O3S
Molecular Weight398.43
CAS Registry Number1226781-44-7



TERT-BUTYL ((2R,3S)-2-(2,5-DIFLUOROPHENYL)-5-OXOTETRAHYDRO-2H-PYRAN-3-YL)CARBAMATE 951127-25-6
2-(Methylsulfonyl)-2,4,5,6-tetrahydropyrrolo[3,4-c]pyrazole benzenesulfonate 1280210-80-1


Omarigliptin (MK-3102) is an oral hypoglycemic agent of super long-lasting dipeptidyl peptidase-4 (DPP-4) developed by Merck & Co., USA. It is administered orally once a week, being able to produce sustained DPP-4 inhibition with a new mechanism of lowering blood sugar. Meanwhile, it does not increase body weight and not cause hypoglycemia and edema. Its mechanism of action is through inhibiting the degrading of the in vivo dipeptidyl peptidase-4 (DPP-4) on the GLP-1, prolonging the action time of glucagon-like peptide-1 (GLP-1), thereby increasing the blood concentration of the endogenous GLP-1 and GIP, and ultimately improving blood glucose control.

Quality Omarigliptin (MK-3102) [1226781-44-7] for sale
Inquiry Cart 0
Send your message to this supplier
 
*From:
*To: Chongqing Newsin Technology Co., Ltd
*Subject:
*Message:
Characters Remaining: (0/3000)